The collaboration began in September, 2012 with an important announcement for DEINOVE: the green biotechnology company produces 2nd Generation Bioethanol thanks to its “all-in-one” Deinococcus bacteria, as part of collaborative program (“DEINOL”) supported by OSEO.
It is a world first which happens while the minister of Agriculture Stephane Le Foll is announces a “break” in [...]
The roundtable will be held May 15, 2012 at the Oceanographic Institute of Paris (5th arrondissement).
All aspects of innate immunity – from the fundamentals to clinical trials – will be covered by our expert speakers:
Two 2011 Nobel prize winners in medicine, Dr. Jules Hoffmann from the Institute of Molecular and Cellular Biology at [...]
ATCG-Partners contributes to the valorisation of translational medicine activities at Paoli-Calmettes Institute and its main therapeutic fields: haematology, breast cancers, digestive and urogenital cancers.
Visit the dedicated website: research.institutpaolicalmettes.fr
A new path to stimulate the immune system and fight against infections – Science Magazine January 20, 2012
A research lead by Eric Vivier and Sophie Ugolini of the Centre d’Immunologie de Marseille-Luminy (CIML – Inserm/CNRS/Aix Marseille Université) has revealed a new gene that, when mutated, stimulates the immune systems to fight better against tumours [...]
Housed in the new Infectiology Centre of Lyon, Platine Pharma Services provides immuno-monitoring services for clinicians and biopharma industries working on the pre-clinical and clinical development of future drugs.
The agency was in charge of the brand positioning and the website creation and development for this new company created in April 2011 by Transgene [...]
(PRINCETON, New Jersey, and MARSEILLE, France, July 6, 2011) – Bristol-Myers Squibb Company (NYSE: BMY) and Innate Pharma S.A. (Euronext Paris: FR0010331421, IPH) today announced a global agreement for the development and commercialization of IPH2102, a novel antibody in Phase I development for the treatment of cancer.
More in www.innate-pharma.com
IPSOGEN S.A. (Alternext: ALIPS, ISIN: FR0010626028), Cancer Profiler, who develops, manufactures and commercializes molecular diagnostic assays for leukemia and breast cancer announces today that QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) has made an offer and entered into exclusive negotiations to purchase a 47% initial stake in IPSOGEN S.A. and subsequently make a voluntary public [...]
A rich knowledge base cleverly organised to reach each specific audience, a modular logo highlighting the different facets of this world-renowned research institute, and a savvy tagline, “immunology in all its states”, showcasing its ability to explore all fields of its discipline on many models and at various scales.